A freeze placed this year on their use to treat gender dysphoria will remain in place for young people under 18, except in clinical trials, Britain’s government said.
Related Posts
Northvolt, Europe’s Hope for a Battery Champion, Files for Bankruptcy
The company’s woes are symptomatic of a wider malaise among companies that make batteries for electric vehicles.
Evan Gershkovich, Wall Street Journal Reporter, Returns to Court in Russia
The hearing was the second in the espionage trial of Mr. Gershkovich, a reporter for The Wall Street Journal. The…
With Hostage Swap, Biden Scores a Win as His Term Nears Its End
The prisoner exchange offered a measure of validation for President Biden soon after he abandoned his bid for re-election.